Cross-Sectional Analysis of Renal Transplantation Osteoporosis
Open Access
- 1 November 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 14 (11) , 1943-1951
Abstract
We report a cross-sectional study of 54 adult female renal transplant recipients. We measured bone mineral density (BMD) of the lumbar spine, femoral neck, total hip, and mid- and total radius, and 38 patients underwent transiliac crest bone biopsy. Osteopenia was widespread with 31/54 (57%) of patients osteoporotic at one or more sites. Seventeen out of 54 (32%) of the patients had a prevalent low-trauma fracture. There was a clear trend in BMD reduction across spine, hip and midradius, with the predominantly cortical midradial site showing the greatest loss. We found no relationship between BMD and body mass index, parathyroid hormone (PTH), dose of immunosuppressant, years since transplantation, age at menopause, or years since menopause. Histologically, abnormal biopsies could be classified into three categories: hyperparathyroid (n = 20), adynamic (n = 14), and osteomalacic (n = 2). Mean PTH was lower (p = NS) and mean cumulative prednisolone dose was higher (p = 0.04) in the adynamic group compared with the hyperparathyroid group, but because of overlap between groups neither was an effective discriminator of histology. We suggest that bone biopsy is indicated in these patients to direct appropriate treatment. At the cellular level, there were significant negative correlations between osteoclast function (eroded surface, r = 0.47, p = 0.003) and osteoblast numbers (osteoblast surface, r = –0.40, p = 0.01) and cumulative exposure to prednisolone. We postulate that suppression of osteoblast function by prednisolone with unopposed bone resorption may result in relative hypercalcaemia and low PTH. This progressive reduction in bone turnover may promote or prolong the adynamic state.Keywords
This publication has 20 references indexed in Scilit:
- Increased Risk of Fracture in Patients Receiving Solid Organ TransplantsJournal of Bone and Mineral Research, 1999
- What are the bone lesions in patients with more than four years of a functioning renal transplant?Nephrology Dialysis Transplantation, 1998
- Post-transplantation bone disease: The role of immunosuppressive agents and the skeletonJournal of Bone and Mineral Research, 1996
- Adynamic bone lesion in renal transplant recipients with normal renal functionNephrology Dialysis Transplantation, 1996
- The aplastic form of renal osteodystrophyNephrology Dialysis Transplantation, 1996
- Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapyKidney International, 1994
- Age related histomorphometric changes in bone in normal British men and women.Journal of Clinical Pathology, 1994
- Loss of Regional Bone Mineral Density in the First 12 Months following Renal TransplantationNephron, 1994
- Histological, Radiological, and Biochemical Features of the Adynamic Bone Lesion in Continuous Ambulatory Peritoneal Dialysis PatientsAmerican Journal of Nephrology, 1994
- Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid functionKidney International, 1993